IFP Advisors’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $342K | Buy |
1,754
+501
| +40% | +$104K | 0.01% | 1221 |
|
|
2026
Q1 | $281K | Buy |
1,253
+56
| +5% | +$14K | 0.01% | 1234 |
|
|
2025
Q4 | $288K | Buy |
1,197
+92
| +8% | +$23.5K | 0.01% | 1187 |
|
|
2025
Q3 | $302K | Buy |
1,105
+360
| +48% | +$98.3K | 0.01% | 1092 |
|
|
2025
Q2 | $251K | Buy |
745
+375
| +101% | +$89.5K | 0.01% | 1155 |
|
|
2025
Q1 | $82.9K | Sell |
370
-3
| -0.8% | -$700 | ﹤0.01% | 1634 |
|
|
2024
Q4 | $85.3K | Buy |
373
+101
| +37% | +$24.3K | ﹤0.01% | 1550 |
|
|
2024
Q3 | $66.4K | Buy |
272
+163
| +150% | +$36.4K | ﹤0.01% | 1595 |
|
|
2024
Q2 | $20.9K | Buy |
109
+25
| +30% | +$5.07K | ﹤0.01% | 2063 |
|
|
2024
Q1 | $16.6K | Buy |
84
+6
| +8% | +$1.1K | ﹤0.01% | 2060 |
|
|
2023
Q4 | $13.4K | Sell |
78
-273
| -78% | -$41.9K | ﹤0.01% | 2078 |
|
|
2023
Q3 | $51.9K | Hold |
351
| – | – | ﹤0.01% | 1534 |
|
|
2023
Q2 | $76.7K | Sell |
351
-1
| -0.3% | -$223 | ﹤0.01% | 1437 |
|
|
2023
Q1 | $36.5K | Sell |
352
-420
| -54% | -$91.1K | ﹤0.01% | 1737 |
|
|
2022
Q4 | $83K | Sell |
772
-48
| -6% | -$10.5K | ﹤0.01% | 1869 |
|
|
2022
Q3 | $89K | Buy |
820
+102
| +14% | +$23.2K | ﹤0.01% | 1942 |
|
|
2022
Q2 | $79K | Hold |
718
| – | – | ﹤0.01% | 1847 |
|
|
2022
Q1 | $79K | Buy |
718
+34
| +5% | +$8.22K | ﹤0.01% | 1847 |
|
|
2021
Q4 | $179K | Sell |
684
-13
| -2% | -$3.37K | ﹤0.01% | 1000 |
|
|
2021
Q3 | $185K | Sell |
697
-154
| -18% | -$42.1K | ﹤0.01% | 994 |
|
|
2021
Q2 | $210K | Buy |
851
+155
| +22% | +$32.6K | ﹤0.01% | 881 |
|
|
2021
Q1 | $136K | Buy |
696
+4
| +0.6% | +$802 | ﹤0.01% | 1019 |
|
|
2020
Q4 | $150K | Sell |
692
-3
| -0.4% | -$598 | 0.01% | 934 |
|
|
2020
Q3 | $119K | Hold |
695
| – | – | 0.01% | 912 |
|
|
2020
Q2 | $134K | Sell |
695
-65
| -9% | -$10.6K | 0.01% | 813 |
|
|
2020
Q1 | $113K | Sell |
760
-14
| -2% | -$2.23K | 0.01% | 779 |
|
|
2019
Q4 | $121K | Hold |
774
| – | – | 0.01% | 855 |
|
|
2019
Q3 | $102K | Buy |
+774
| New | +$101K | 0.01% | 1051 |
|
|
2019
Q1 | $9K | Sell |
91
-578
| -86% | -$59.7K | ﹤0.01% | 1670 |
|
|
2018
Q4 | $75K | Sell |
669
-66
| -9% | -$7.07K | ﹤0.01% | 1361 |
|
|
2018
Q3 | $85K | Buy |
735
+281
| +62% | +$30.8K | ﹤0.01% | 1584 |
|
|
2018
Q2 | $47K | Buy |
454
+165
| +57% | +$16.7K | ﹤0.01% | 1957 |
|
|
2018
Q1 | $25K | Hold |
289
| – | – | ﹤0.01% | 2250 |
|
|
2017
Q4 | $25K | Sell |
289
-114
| -28% | -$9.42K | ﹤0.01% | 2280 |
|
|
2017
Q3 | $31K | Sell |
403
-48
| -11% | -$3.67K | ﹤0.01% | 2319 |
|
|
2017
Q2 | $35K | Sell |
451
-167
| -27% | -$11.9K | ﹤0.01% | 2215 |
|
|
2017
Q1 | $44K | Buy |
618
+69
| +13% | +$4.77K | ﹤0.01% | 2001 |
|
|
2016
Q4 | $34K | Buy |
549
+330
| +151% | +$20.2K | ﹤0.01% | 2107 |
|
|
2016
Q3 | $14K | Buy |
219
+20
| +10% | +$1.33K | ﹤0.01% | 2629 |
|
|
2016
Q2 | $13K | Buy |
199
+108
| +119% | +$6.37K | ﹤0.01% | 2624 |
|
|
2016
Q1 | $9K | Sell |
91
-7
| -7% | -$396 | ﹤0.01% | 1668 |
|
|
2015
Q4 | $5K | Buy |
+98
| New | +$5.52K | ﹤0.01% | 2982 |
|
Other funds holding RMD
AT
DJSG
CIM
AC
MPWT
NAM
CNB
IFP Advisors's RMD Position: Q2 2026 in Review
IFP Advisors increased its ResMed (RMD) stake by 40% in Q2 2026, buying an estimated $104K and bringing the position to 1,754 shares worth $342K. The position accounts for 0.01% of the portfolio, ranked #1221.
IFP Advisors first reported a position in RMD in Q4 2015 and has held it in 42 quarters since. 142 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- IFP Advisors held 1,754 shares of ResMed worth $342K as of Q2 2026.
- IFP Advisors bought 501 ResMed shares in Q2 2026, an estimated $104K.
- ResMed made up 0.01% of IFP Advisors's portfolio in Q2 2026, its #1221 holding.
- IFP Advisors first reported a position in ResMed in Q4 2015 and has held it in 42 quarters since.
- 142 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.